deferasirox
Generic: deferasirox
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
deferasirox
Generic Name
deferasirox
Labeler
aurobindo pharma limited
Dosage Form
GRANULE
Routes
Active Ingredients
deferasirox 180 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59651-448
Product ID
59651-448_c220484e-1e6a-4a0c-a221-60223f3bc24c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215137
Listing Expiration
2026-12-31
Marketing Start
2025-09-08
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59651448
Hyphenated Format
59651-448
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
deferasirox (source: ndc)
Generic Name
deferasirox (source: ndc)
Application Number
ANDA215137 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 180 mg/1
Packaging
- 30 PACKET in 1 CARTON (59651-448-30) / 1 GRANULE in 1 PACKET (59651-448-77)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c220484e-1e6a-4a0c-a221-60223f3bc24c", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "unii": ["V8G4MOF2V9"], "rxcui": ["1923822", "1923826", "1923828"], "spl_set_id": ["c220484e-1e6a-4a0c-a221-60223f3bc24c"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (59651-448-30) / 1 GRANULE in 1 PACKET (59651-448-77)", "package_ndc": "59651-448-30", "marketing_start_date": "20250908"}], "brand_name": "DEFERASIROX", "product_id": "59651-448_c220484e-1e6a-4a0c-a221-60223f3bc24c", "dosage_form": "GRANULE", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "59651-448", "generic_name": "DEFERASIROX", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DEFERASIROX", "active_ingredients": [{"name": "DEFERASIROX", "strength": "180 mg/1"}], "application_number": "ANDA215137", "marketing_category": "ANDA", "marketing_start_date": "20250908", "listing_expiration_date": "20261231"}